To further explore whether galactin-3-TREM2 interaction affects the progression of lung cancer, we established a subcutaneous transplantation tumor model of lung cancer in WT and TREM2f/f-Lyz2-Cre mice and administered GB1107 treatment daily (Fig. 7A). This evidence concerns the gene TREM2 and neoplasm.